These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1257 related items for PubMed ID: 23830153

  • 1. Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes.
    Graff SK, Mário FM, Alves BC, Spritzer PM.
    Fertil Steril; 2013 Oct; 100(4):1081-8. PubMed ID: 23830153
    [Abstract] [Full Text] [Related]

  • 2. Insulin resistance is not strictly associated with energy intake or dietary macronutrient composition in women with polycystic ovary syndrome.
    Toscani MK, Mario FM, Radavelli-Bagatini S, Spritzer PM.
    Nutr Res; 2011 Feb; 31(2):97-103. PubMed ID: 21419313
    [Abstract] [Full Text] [Related]

  • 3. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
    Panidis D, Farmakiotis D, Rousso D, Kourtis A, Katsikis I, Krassas G.
    Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
    [Abstract] [Full Text] [Related]

  • 4. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R, Gambineri A, Biscotti D, Vicennati V, Gagliardi L, Colitta D, Fiorini S, Cognigni GE, Filicori M, Morselli-Labate AM.
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
    [Abstract] [Full Text] [Related]

  • 5. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
    Shi Y, Guo M, Yan J, Sun W, Zhang X, Geng L, Xu L, Chen Z.
    Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
    [Abstract] [Full Text] [Related]

  • 6. Lean muscle mass in classic or ovulatory PCOS: association with central obesity and insulin resistance.
    Mario FM, do Amarante F, Toscani MK, Spritzer PM.
    Exp Clin Endocrinol Diabetes; 2012 Oct; 120(9):511-6. PubMed ID: 22576259
    [Abstract] [Full Text] [Related]

  • 7. Relationship between androgen levels and blood pressure in young women with polycystic ovary syndrome.
    Chen MJ, Yang WS, Yang JH, Chen CL, Ho HN, Yang YS.
    Hypertension; 2007 Jun; 49(6):1442-7. PubMed ID: 17389259
    [Abstract] [Full Text] [Related]

  • 8. Effect of long-term orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndrome.
    Diamanti-Kandarakis E, Katsikis I, Piperi C, Alexandraki K, Panidis D.
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):103-9. PubMed ID: 17201808
    [Abstract] [Full Text] [Related]

  • 9. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA, Hassan S, Nisar S, Shamas N, Rashid A, Ahmed I, Douhat S, Mudassar S, Jan VM, Rashid F.
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [Abstract] [Full Text] [Related]

  • 10. Dietary intake, glucose metabolism and sex hormones in women with polycystic ovary syndrome (PCOS) compared with women with non-PCOS-related infertility.
    Tsai YH, Wang TW, Wei HJ, Hsu CY, Ho HJ, Chen WH, Young R, Liaw CM, Chao JC.
    Br J Nutr; 2013 Jun 28; 109(12):2190-8. PubMed ID: 23046530
    [Abstract] [Full Text] [Related]

  • 11. Serum antimüllerian hormone in response to dietary management and/or physical exercise in overweight/obese women with polycystic ovary syndrome: secondary analysis of a randomized controlled trial.
    Nybacka Å, Carlström K, Fabri F, Hellström PM, Hirschberg AL.
    Fertil Steril; 2013 Oct 28; 100(4):1096-102. PubMed ID: 23876536
    [Abstract] [Full Text] [Related]

  • 12. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome.
    Ardawi MS, Rouzi AA.
    Fertil Steril; 2005 Jun 28; 83(6):1708-16. PubMed ID: 15950640
    [Abstract] [Full Text] [Related]

  • 13. Prevalence of the metabolic syndrome in women with a previous diagnosis of polycystic ovary syndrome: long-term follow-up.
    Hudecova M, Holte J, Olovsson M, Larsson A, Berne C, Sundstrom-Poromaa I.
    Fertil Steril; 2011 Nov 28; 96(5):1271-4. PubMed ID: 21872228
    [Abstract] [Full Text] [Related]

  • 14. Vigorous exercise is associated with superior metabolic profiles in polycystic ovary syndrome independent of total exercise expenditure.
    Greenwood EA, Noel MW, Kao CN, Shinkai K, Pasch LA, Cedars MI, Huddleston HG.
    Fertil Steril; 2016 Feb 28; 105(2):486-93. PubMed ID: 26551442
    [Abstract] [Full Text] [Related]

  • 15. Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome.
    Tziomalos K, Katsikis I, Papadakis E, Kandaraki EA, Macut D, Panidis D.
    Hum Reprod; 2013 Mar 28; 28(3):785-93. PubMed ID: 23315058
    [Abstract] [Full Text] [Related]

  • 16. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
    Barber TM, Wass JA, McCarthy MI, Franks S.
    Clin Endocrinol (Oxf); 2007 Apr 28; 66(4):513-7. PubMed ID: 17371468
    [Abstract] [Full Text] [Related]

  • 17. Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life.
    Pinola P, Puukka K, Piltonen TT, Puurunen J, Vanky E, Sundström-Poromaa I, Stener-Victorin E, Lindén Hirschberg A, Ravn P, Skovsager Andersen M, Glintborg D, Mellembakken JR, Ruokonen A, Tapanainen JS, Morin-Papunen LC.
    Fertil Steril; 2017 Mar 28; 107(3):788-795.e2. PubMed ID: 28089571
    [Abstract] [Full Text] [Related]

  • 18. Cross-sectional analysis of the effects of age on the hormonal, metabolic, and ultrasonographic features and the prevalence of the different phenotypes of polycystic ovary syndrome.
    Panidis D, Tziomalos K, Macut D, Delkos D, Betsas G, Misichronis G, Katsikis I.
    Fertil Steril; 2012 Feb 28; 97(2):494-500. PubMed ID: 22192350
    [Abstract] [Full Text] [Related]

  • 19. Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescents.
    Glueck CJ, Morrison JA, Friedman LA, Goldenberg N, Stroop DM, Wang P.
    Metabolism; 2006 Apr 28; 55(4):508-14. PubMed ID: 16546482
    [Abstract] [Full Text] [Related]

  • 20. Body fat composition and distribution in women with polycystic ovary syndrome.
    Cosar E, Uçok K, Akgün L, Köken G, Sahin FK, Arioz DT, Baş O.
    Gynecol Endocrinol; 2008 Aug 28; 24(8):428-32. PubMed ID: 18850379
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 63.